Literature DB >> 19470615

Mouse models of altered protein kinase A signaling.

Lawrence S Kirschner1, Zhirong Yin, Georgette N Jones, Emilia Mahoney.   

Abstract

Protein kinase A (PKA) is an evolutionarily conserved protein which has been studied in model organisms from yeast to man. Although the cAMP-PKA signaling system was the first mammalian second messenger system to be characterized, many aspects of this pathway are still not well understood. Owing to findings over the past decade implicating PKA signaling in endocrine (and other) tumorigenesis, there has been renewed interest in understanding the role of this pathway in physiology, particularly as it pertains to the endocrine system. Because of the availability of genetic tools, mouse modeling has become the pre-eminent system for studying the physiological role of specific genes and gene families as a means to understanding their relationship to human diseases. In this review, we will summarize the current data regarding mouse models that have targeted the PKA signaling system. These data have led to a better understanding of both the complexity and the subtlety of PKA signaling, and point the way for future studies, which may help to modulate this pathway for therapeutic effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19470615     DOI: 10.1677/ERC-09-0068

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  34 in total

Review 1.  PRKAR1A and the evolution of pituitary tumors.

Authors:  Lawrence S Kirschner
Journal:  Mol Cell Endocrinol       Date:  2010-05-06       Impact factor: 4.102

2.  Neural crest-specific loss of Prkar1a causes perinatal lethality resulting from defects in intramembranous ossification.

Authors:  Georgette N Jones; Daphne R Pringle; Zhirong Yin; Michelle M Carlton; Kimerly A Powell; Michael B Weinstein; Ramiro E Toribio; Krista M D La Perle; Lawrence S Kirschner
Journal:  Mol Endocrinol       Date:  2010-06-09

Review 3.  Anthrax lethal and edema toxins in anthrax pathogenesis.

Authors:  Shihui Liu; Mahtab Moayeri; Stephen H Leppla
Journal:  Trends Microbiol       Date:  2014-03-27       Impact factor: 17.079

4.  Two PKA RIα holoenzyme states define ATP as an isoform-specific orthosteric inhibitor that competes with the allosteric activator, cAMP.

Authors:  Tsan-Wen Lu; Jian Wu; Phillip C Aoto; Jui-Hung Weng; Lalima G Ahuja; Nicholas Sun; Cecilia Y Cheng; Ping Zhang; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-30       Impact factor: 11.205

5.  Interaction of the regulatory subunit of the cAMP-dependent protein kinase with PATZ1 (ZNF278).

Authors:  Weng-Lang Yang; Roald Ravatn; Kazuya Kudoh; Leah Alabanza; Khew-Voon Chin
Journal:  Biochem Biophys Res Commun       Date:  2009-12-22       Impact factor: 3.575

6.  Conduction in the right and left ventricle is differentially regulated by protein kinases and phosphatases: implications for arrhythmogenesis.

Authors:  Alexey V Zaitsev; Natalia S Torres; Keiko M Cawley; Amira D Sabry; Junco S Warren; Mark Warren
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-15       Impact factor: 4.733

Review 7.  G-protein-coupled receptor signaling and neural tube closure defects.

Authors:  Issei S Shimada; Saikat Mukhopadhyay
Journal:  Birth Defects Res       Date:  2017-01-30       Impact factor: 2.344

8.  Expression of BANCR promotes papillary thyroid cancer by targeting thyroid stimulating hormone receptor.

Authors:  Haitao Zheng; Jie Xu; Shaolong Hao; Xincheng Liu; Jinrao Ning; Xicheng Song; Lixin Jiang; Zongying Liu
Journal:  Oncol Lett       Date:  2018-05-25       Impact factor: 2.967

9.  Interaction of AIP with protein kinase A (cAMP-dependent protein kinase).

Authors:  Marie Helene Schernthaner-Reiter; Giampaolo Trivellin; Constantine A Stratakis
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

Review 10.  Lessons from mouse models of thyroid cancer.

Authors:  Caroline S Kim; Xuguang Zhu
Journal:  Thyroid       Date:  2009-12       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.